759 related articles for article (PubMed ID: 32580376)
1. Pharmacogenomics and Personalized Medicine.
Cecchin E; Stocco G
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
[TBL] [Abstract][Full Text] [Related]
2. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
Cecchin E; De Mattia E; Ecca F; Toffoli G
Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
[TBL] [Abstract][Full Text] [Related]
3. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
Nagy M; Attya M; Patrinos GP
Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
[TBL] [Abstract][Full Text] [Related]
5. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
[TBL] [Abstract][Full Text] [Related]
6. Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
Chang WC; Tanoshima R; Ross CJD; Carleton BC
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():65-84. PubMed ID: 33006916
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.
Lauschke VM; Milani L; Ingelman-Sundberg M
AAPS J; 2017 Nov; 20(1):4. PubMed ID: 29181807
[TBL] [Abstract][Full Text] [Related]
8. Implementation of pharmacogenomics into inpatient general medicine.
Chen T; O'Donnell PH; Middlestadt M; Ruhnke GW; Danahey K; van Wijk XMR; Choksi A; Knoebel R; Hartman S; Yeo KJ; Friedman PN; Ratain MJ; Nutescu EA; O'Leary KJ; Perera MA; Meltzer DO
Pharmacogenet Genomics; 2023 Feb; 33(2):19-23. PubMed ID: 36729768
[TBL] [Abstract][Full Text] [Related]
9. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
[TBL] [Abstract][Full Text] [Related]
10. Developments in pharmacogenetics, pharmacogenomics, and personalized medicine.
Abad-Santos F; Aliño SF; Borobia AM; García-Martín E; Gassó P; Maroñas O; Agúndez JAG
Pharmacol Res; 2024 Feb; 200():107061. PubMed ID: 38199278
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics in Pain Management: A Review of Relevant Gene-Drug Associations and Clinical Considerations.
Brandl E; Halford Z; Clark MD; Herndon C
Ann Pharmacother; 2021 Dec; 55(12):1486-1501. PubMed ID: 33771051
[TBL] [Abstract][Full Text] [Related]
12. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
Borden BA; Galecki P; Wellmann R; Danahey K; Lee SM; Patrick-Miller L; Sorrentino MJ; Nanda R; Koyner JL; Polonsky TS; Stadler WM; Mulcahy C; Kavitt RT; Ratain MJ; Meltzer DO; O'Donnell PH
Pharmacogenet Genomics; 2019 Feb; 29(2):31-38. PubMed ID: 30531377
[TBL] [Abstract][Full Text] [Related]
13. Prioritizing pharmacogenomics implementation initiates: a survey of healthcare professionals.
Ho TT; Gift M; Alexander E
Per Med; 2022 Jan; 19(1):15-23. PubMed ID: 34881640
[TBL] [Abstract][Full Text] [Related]
14. Significance of Pharmacogenomics in Precision Medicine.
Cascorbi I
Clin Pharmacol Ther; 2018 May; 103(5):732-735. PubMed ID: 29660122
[TBL] [Abstract][Full Text] [Related]
15. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
Arbitrio M; Di Martino MT; Scionti F; Agapito G; Guzzi PH; Cannataro M; Tassone P; Tagliaferri P
Oncotarget; 2016 Aug; 7(33):54028-54050. PubMed ID: 27304055
[TBL] [Abstract][Full Text] [Related]
16. Deliberations about clinical pharmacogenetic testing in pediatric oncology.
Issa AM; Aboushawareb SA; Eisenstat DD; Guilcher GM; Liu G; Rassekh SR; Strahlendorf C; Tallen G; Tanoshima R; Carleton B
Per Med; 2021 Jul; 18(4):399-405. PubMed ID: 33973801
[TBL] [Abstract][Full Text] [Related]
17. Precision medicine from a citizen perspective: a survey of public attitudes towards pharmacogenomics in Flanders.
Edris A; Callier E; Lahousse L
BMC Med Genomics; 2022 Sep; 15(Suppl 3):193. PubMed ID: 36096833
[TBL] [Abstract][Full Text] [Related]
18. Implementation of wide-scale pharmacogenetic testing in primary care.
Natasha Petry ; Baye J; Aifaoui A; Wilke RA; Lupu RA; Savageau J; Gapp B; Massmann A; Hahn D; Hajek C; Schultz A
Pharmacogenomics; 2019 Aug; 20(12):903-913. PubMed ID: 31453774
[TBL] [Abstract][Full Text] [Related]
19. Genetic Variation among Pharmacogenes in the Sardinian Population.
Idda ML; Zoledziewska M; Urru SAM; McInnes G; Bilotta A; Nuvoli V; Lodde V; Orrù S; Schlessinger D; Cucca F; Floris M
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077453
[TBL] [Abstract][Full Text] [Related]
20. Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicine.
Biswas M; Shobana J; Jinda P; Sukasem C
Expert Opin Drug Metab Toxicol; 2023 Mar; 19(3):165-174. PubMed ID: 37089014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
